Ngm Biopharmaceuticals Inc (NGM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 256,952 | 245,598 | 303,016 | 265,072 | 47,313 |
| Marketable Securities | 71,517 | 98,913 | 53,557 | 97,116 | 146,126 |
| Receivables | 742 | 5,206 | N/A | 881 | N/A |
| TOTAL | $338,307 | $355,248 | $364,320 | $368,344 | $199,145 |
| Non-Current Assets | |||||
| PPE Net | 18,274 | 19,475 | 20,485 | 22,172 | 23,319 |
| Other Non-Current Assets | 4,120 | 5,680 | 5,810 | 6,187 | 9,163 |
| TOTAL | $22,394 | $25,155 | $26,295 | $28,359 | $32,482 |
| Total Assets | $360,701 | $380,403 | $390,615 | $396,703 | $231,627 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,648 | 9,026 | 4,457 | 3,164 | 4,203 |
| Accrued Expenses | 21,949 | 22,991 | 18,605 | 15,292 | 13,916 |
| Other current liabilities | 2,865 | 4,872 | 2,792 | 2,756 | 2,719 |
| TOTAL | $28,462 | $39,718 | $40,478 | $38,653 | $42,879 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | 2,829 | 14,624 | 17,441 | 22,041 |
| Other Non-Current Liabilities | 13,267 | 574 | 10,951 | 11,920 | 307,926 |
| TOTAL | $13,267 | $9,966 | $10,951 | $11,920 | $307,926 |
| Total Liabilities | $41,729 | $49,684 | $51,429 | $50,573 | $350,805 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 68,142 | 67,753 | 66,655 | 66,043 | 66,022 |
| Common Shares | 68 | 67 | 66 | 66 | 7 |
| Retained earnings | -215,259 | -196,144 | -180,203 | -169,286 | -161,617 |
| Other shareholders' equity | -55 | 25 | 99 | 102 | -45 |
| TOTAL | $318,972 | $330,719 | $339,186 | $346,130 | $-119,178 |
| Total Liabilities And Equity | $360,701 | $380,403 | $390,615 | $396,703 | $231,627 |